| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Is Dispensible for v-rasHa-induced Epidermal Neoplasia: Potential Involvement of Alternate Epidermal Growth Factor Receptor Ligands1
Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892 [A. A. D., C. C., E. K. W., N. D., S. H. Y.]; Departments of Medicine and Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [P. J. D., R. J. C.]; and Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria 3050, Australia [B. M., A. R. D.]
Autocrine epidermal growth factor receptor activation by transforming growth factor
(TGF
) has been implicated in growth stimulation during epithelial neoplasia. Using keratinocytes isolated from mice with genetic defects in TGF
expression, we tested whether TGF
is required for transformation by the v-rasHa oncogene. Introduction of v-rasHa into primary epidermal cultures using a retroviral vector stimulated growth of both control (TGF
+/+, BALB/c) and TGF
-deficient (TGF
-/-, wa-1) keratinocytes. Moreover, v-rasHa elicited characteristic changes in marker expression (keratin 1 was suppressed; keratin 8 was induced), previously shown to be associated with epidermal growth factor (EGF) receptor activation, in both TGF
+/+ and TGF
-/- keratinocytes. v-rasHa markedly increased secreted (>10-fold) and cell-associated (23-fold) TGF
levels in keratinocytes from TGF
+/+ and BALB/c mice, but not TGF
-/- or wa-1 mice. Based on Northern blot analysis, v-rasHa induced striking up-regulation of transcripts encoding the additional EGF family members amphiregulin, heparin-binding EGF-like growth factor, and betacellulin in cultured keratinocytes from all four mouse strains. Interestingly, in addition to the normal 4.5-kilobase TGF
transcript, wa-1 keratinocytes expressed two additional TGF
transcripts, 4.7 and 5.2 kilobases long. All three transcripts were up-regulated in response to v-rasHa, as well as exogenous TGF
or keratinocyte growth factor treatment, and were also detected in RNA isolated from wa-1 brain and skin. In vivo, v-rasHa keratinocytes from control as well as TGF
-deficient mice produced squamous tumors when grafted onto nude mice, and these lesions expressed high levels of amphiregulin, heparin-binding EGF-like growth factor, and betacellulin mRNA, regardless of their TGF
status. These findings indicate that TGF
is not essential for epidermal neoplasia induced by the v-rasHa oncogene and suggest that another EGF family member(s) may contribute to autocrine growth stimulation of ras-transformed keratinocytes.
1 This work was supported in part by a Thomas B. Fitzpatrick-Kao Corporation Research Award (A. A. D.), and by Grant MCICA46413 and by the Veterans Administration (R. J. C.). R. J. C. is a Veterans Administration Clinical Investigator.
2 To whom requests for reprints should be addressed, at LCCTP/NCI, Bldg 37/Rm 3B08, 37 Convent DR MSC 4255, Bethesda, MD 20892-4255.
Received 12/ 1/94. Accepted 2/24/95.
This article has been cited by other articles:
![]() |
C. Cataisson, R. Ohman, G. Patel, A. Pearson, M. Tsien, S. Jay, L. Wright, H. Hennings, and S. H. Yuspa Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis Cancer Res., January 1, 2009; 69(1): 319 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Schneider, S. Werner, R. Paus, and E. Wolf Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology Am. J. Pathol., July 1, 2008; 173(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Stepp, Y. Liu, S. Pal-Ghosh, R. A. Jurjus, G. Tadvalkar, A. Sekaran, K. LoSicco, L. Jiang, M. Larsen, L. Li, et al. Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1 J. Cell Sci., August 15, 2007; 120(16): 2851 - 2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujimoto, M. Wislez, J. Zhang, K. Iwanaga, J. Dackor, A. E. Hanna, S. Kalyankrishna, D. D. Cody, R. E. Price, M. Sato, et al. High Expression of ErbB Family Members and Their Ligands in Lung Adenocarcinomas That Are Sensitive to Inhibition of Epidermal Growth Factor Receptor Cancer Res., December 15, 2005; 65(24): 11478 - 11485. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kansra, S. W. Stoll, J. L. Johnson, and J. T. Elder Autocrine Extracellular Signal-regulated Kinase (ERK) Activation in Normal Human Keratinocytes: Metalloproteinase-mediated Release of Amphiregulin Triggers Signaling from ErbB1 to ERK Mol. Biol. Cell, September 1, 2004; 15(9): 4299 - 4309. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Billings, M. D. Southall, T. Li, P. W. Cook, L. Baldridge, W. B. Moores, D. F. Spandau, J. G. Foley, and J. B. Travers Amphiregulin Overexpression Results in Rapidly Growing Keratinocytic Tumors: An In Vivo Xenograft Model of Keratoacanthoma Am. J. Pathol., December 1, 2003; 163(6): 2451 - 2458. [Abstract] [Full Text] |
||||
![]() |
X. Liu, J. Lee, M. Cooley, E. Bhogte, S. Hartley, and A. Glick Smad7 but not Smad6 Cooperates with Oncogenic ras to Cause Malignant Conversion in a Mouse Model for Squamous Cell Carcinoma Cancer Res., November 15, 2003; 63(22): 7760 - 7768. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Grana, C. I. Sartor, and A. D. Cox Epidermal Growth Factor Receptor Autocrine Signaling in RIE-1 Cells Transformed by the Ras Oncogene Enhances Radiation Resistance Cancer Res., November 15, 2003; 63(22): 7807 - 7814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Abbott, A. R. Buckalew, M. J. DeVito, D. Ross, P. L. Bryant, and J. E. Schmid EGF and TGF-{alpha} Expression Influence the Developmental Toxicity of TCDD: Dose Response and AhR Phenotype in EGF, TGF-{alpha}, and EGF + TGF-{alpha} Knockout Mice Toxicol. Sci., January 1, 2003; 71(1): 84 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Casanova, F. Larcher, B. Casanova, R. Murillas, M. J. Fernandez-Acenero, C. Villanueva, J. Martinez-Palacio, A. Ullrich, C. J. Conti, and J. L. Jorcano A Critical Role for ras-mediated, Epidermal Growth Factor Receptor-dependent Angiogenesis in Mouse Skin Carcinogenesis Cancer Res., June 1, 2002; 62(12): 3402 - 3407. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Bryant, J. E. Schmid, S. E. Fenton, A. R. Buckalew, and B. D. Abbott Teratogenicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in Mice Lacking the Expression of EGF and/or TGF-{{alpha}} Toxicol. Sci., July 1, 2001; 62(1): 103 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Reddig, N. E. Dreckschimdt, H. Ahrens, R. Simsiman, C.-P. Tseng, J. Zou, T. D. Oberley, and A. K. Verma Transgenic Mice Overexpressing Protein Kinase C{{delta}} in the Epidermis Are Resistant to Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-acetate Cancer Res., November 1, 1999; 59(22): 5710 - 5718. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Opanashuk, R. J. Mark, J. Porter, D. Damm, M. P. Mattson, and K. B. Seroogy Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti-Excitotoxic Action J. Neurosci., January 1, 1999; 19(1): 133 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Humble, C. J. Szczesniak, N. C. Luetteke, J. W. Spalding, R. E. Cannon, L. A. Hansen, D. C. Lee, and R. W. Tennant TGF{alpha} is Dispensable for Skin Tumorigenesis in Tg.AC Mice Toxicol Pathol, July 1, 1998; 26(4): 562 - 569. [Abstract] [PDF] |
||||
![]() |
L. M. Gangarosa, N. Sizemore, R. Graves-Deal, S. M. Oldham, C. J. Der, and R. J. Coffey A Raf-independent Epidermal Growth Factor Receptor Autocrine Loop Is Necessary for Ras Transformation of Rat Intestinal Epithelial Cells J. Biol. Chem., July 25, 1997; 272(30): 18926 - 18931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Denning, A. A. Dlugosz, D. W. Threadgill, T. Magnuson, and S. H. Yuspa Activation of the Epidermal Growth Factor Receptor Signal Transduction Pathway Stimulates Tyrosine Phosphorylation of Protein Kinase C [IMAGE] J. Biol. Chem., March 8, 1996; 271(10): 5325 - 5331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |